Skip to main content

Table 4 Univariate analysis of factors associated with overall survival (OS) and disease-free survival (DFS) of 68 patients with hepatocellular carcinoma

From: Expression of glioma-associated oncogene 2 (Gli 2) is correlated with poor prognosis in patients with hepatocellular carcinoma undergoing hepatectomy

Factor P value
  OS DFS
Gender (male versus female) 0.564 0.867
Age (≤60 versus >60 years) 0.430 0.682
Virus (HBV versus HCV and none) 0.410 0.247
AFP (≤200 versus >200 ng/ml) 0.909 0.626
Cirrhosis (absent versus present) 0.313 0.551
Tumor size (≤50 versus >50 mm) 0.005 * 0.001 *
TNM stage (I to II versus III to IV) 0.034 * 0.056
Differentiation (well and moderate versus poor) 0.011 * 0.110
Tumor number (solitary versus multiple) 0.401 0.741
Tumor encapsulation (intact versus absent or not intact) 0.011 * 0.009 *
Vascular invasion (absent versus present) 0.003 * 0.001 *
Gli2 expression (low versus high) 0.005 * 0.017 *
  1. Abbreviations: AFP, alpha fetoprotein; HBV, hepatitis B virus; HCV, hepatitis C virus; TMN, tumor, node, metastasis.
  2. * P < 0.05.